| ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL S Pietrobono, G Anichini, C Sala, F Manetti, LL Almada, S Pepe, RM Carr, ... Nature communications 11 (1), 5865, 2020 | 57 | 2020 |
| Boundary-value problems with nonlinear boundary conditions G Anichini, G Conti Nonlinearity 1 (4), 531, 1988 | 13 | 1988 |
| The role of the hedgehog pathway in cholangiocarcinoma G Anichini, L Carrassa, B Stecca, F Marra, C Raggi Cancers 13 (19), 4774, 2021 | 11 | 2021 |
| DNA damage response inhibitors in cholangiocarcinoma: current progress and perspectives Ö Gönül Geyik, G Anichini, E Ulukaya, F Marra, C Raggi Cells 11 (9), 1463, 2022 | 6 | 2022 |
| On the existence of solutions for quadratic integral equations on unbounded intervals for quasibounded maps G Anichini, G Conti Rend. Sem. Mat. Univ. Politec. Torino 72, 3-4, 2014 | 5 | 2014 |
| Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth L Maresca, E Crivaro, F Migliorini, G Anichini, A Giammona, S Pepe, ... Pharmacological Research 195, 106858, 2023 | 3 | 2023 |
| Evaluation of coumarin-tagged deferoxamine as a Zr (IV)-based PET/fluorescence dual imaging probe GM Romano, V Zizi, G Salvatore, R Bani, M Mangoni, S Nistri, G Anichini, ... Journal of Inorganic Biochemistry 245, 112259, 2023 | | 2023 |
| Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma G Anichini, C Raggi, M Pastore, L Carrassa, L Maresca, E Crivaro, ... Molecular Cancer Therapeutics 22 (3), 343-356, 2023 | | 2023 |
| COMBINED INHIBITION OF HEDGEHOG SIGNALING AND OF THE DNA DAMAGE CHECKPOINT KINASE Wee1 PREVENTS GROWTH OF INTRAHEPATIC CHOLANGIOCARCINOMA G Anichini, C Raggi, M Pastore, L Carrassa, L Duwe, J Andersen, L Tofani, ... HEPATOLOGY 76, S1416-S1417, 2022 | | 2022 |
| DNA damage response inhibitors in cholangiocarcinoma: current progress and perspectives G Anichini, E Ulukaya, F Marra, C Raggi, ÖG Geyik PubMed, 2022 | | 2022 |
| DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives. Cells 2022, 11, 1463 Ö Gönül Geyik, G Anichini, E Ulukaya, F Marra, C Raggi s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Function and targeting of the Hedgehog signaling in human cholangiocarcinoma and melanoma G Anichini Università di Siena, 2021 | | 2021 |
